Anna jaques hospital
Beth israel deaconess medical center
Brigham and womens hospital
Cape cod hospital
Caritas holy family hospital and medical center
Caritas norwood hospital
Good samaritan medical center
Lawrence general hospital
Lowell general hospital
Massachusetts general hospital
Milford regional medical center
Umass memorial medical center
Brigham & Women's Hospital
Brigham & Women's Hospital
Dana Farber Cancer Institute
A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome.
Ann. Oncol., Jul;22(7):1608-13 (2011)
(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma.
Bone Marrow Transplant., Dec;46(12):1503-9 (2011)
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.
Br. J. Haematol., Jun;145(6):741-8 (2009)
Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning.
J. Clin. Oncol., Dec;26(35):5767-74 (2008)
Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders.
Br. J. Haematol., Nov;143(3):361-8 (2008)
Response to low-dose involved-field radiotherapy in patients with non-Hodgkin's lymphoma.
Ann. Oncol., Dec;19(12):2043-7 (2008)
Antibody and immunomodulatory agents in the treatment of indolent non-Hodgkin's lymphoma.
Semin. Hematol., Apr;45(2):85-9 (2008)
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome.
Biol. Blood Marrow Transplant., Apr;14(4):418-25 (2008)
The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma.
Biol. Blood Marrow Transplant., 7(8):446-53 (2001)
Breast lymphoma associated with breast implants: two case-reports and a review of the literature.
Leuk. Lymphoma., Jan;43(1):115-9 (2002)
Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma.
Biol. Blood Marrow Transplant., 8(8):429-34 (2002)
The role of Aktand RAFTK in beta1 integrin mediated survival of precursor B-acute lymphoblastic leukemia cells.
Leuk. Lymphoma., Aug;43(8):1663-71 (2002)
Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphoma.
Leuk. Lymphoma., Feb;45(2):315-20 (2004)
Hodgkin disease associated with T-cell non-Hodgkin lymphomas: case reports and review of the literature.
Am. J. Clin. Pathol., May;121(5):701-8 (2004)
TGFbeta-mediated activation of Smad1 in B-cell non-Hodgkin's lymphoma and effect on cell proliferation.
Leukemia., Dec;18(12):2015-25 (2004)
Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
J. Clin. Oncol., Apr;23(10):2208-14 (2005)
Biology and management of histologic transformation of indolent lymphoma.
Hematology Am Soc Hematol Educ Program., 314-20 (2005)
Non-transplant-related treatment options in follicular lymphoma.
Biol. Blood Marrow Transplant., Jan;12(1 Suppl 1):53-8 (2006)
Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.
Biol. Blood Marrow Transplant., Sep;13(9):1057-65 (2007)
The related adhesion focal tyrosine kinase differentially phosphorylates p130Cas and the Cas-like protein, p105HEF1.
J. Biol. Chem., Aug;272(32):19719-24 (1997)